Bioequivalence evaluation of two brands of glimepiride 4 mg tablets in healthy subjects.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2005, v. 43, n. 4, p. 203, doi. 10.5414/CPP43203
- By:
- Publication type:
- Article
Works matching DE "AVENTIS Pharmaceuticals Inc."
Results: 10
1
2
PHARMACY CORNER.
- Published in:
- Oncology Nursing Forum, 2000, v. 27, n. 5, p. 855
- Publication type:
- Article
3
PHARMACY CORNER.
- Published in:
- Oncology Nursing Forum, 2000, v. 27, n. 3, p. 549
- Publication type:
- Article
4
Help at Your Fingertips: A Twenty-First Century Response to the Pro Se Phenomenon.
- Published in:
- Vanderbilt Law Review, 2007, v. 60, n. 3, p. 983
- By:
- Publication type:
- Article
5
Enoxaparin sodium Injection: new safety warnings.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 1, p. 23
- Publication type:
- Article
6
2004 Exhibitors.
- Published in:
- Oncology Nursing Forum, 2004, v. 31, n. 2, p. 366
- Publication type:
- Article
7
THE GLOBAL REPORT: News Source for the Clinical Trials Industry from Around the World.
- Published in:
- Applied Clinical Trials, 2007, v. 16, n. 5, p. 22
- Publication type:
- Article
8
Anti-fat wonder drug should be on the market in 2006.
- Published in:
- Chemistry & Industry, 2005, n. 6, p. 8
- By:
- Publication type:
- Article
9
Novartis: white knight for Aventis?
- Published in:
- Chemistry & Industry, 2004, n. 4, p. 4
- By:
- Publication type:
- Article
10
Amgen preserves erythropoietin monopoly for now.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 3, p. 188, doi. 10.1038/85568
- By:
- Publication type:
- Article